Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Gains from Sales and Divestitures (2017 - 2023)

Biolife Solutions (BLFS) has disclosed Gains from Sales and Divestitures for 7 consecutive years, with $346184.0 as the latest value for Q1 2023.

  • Quarterly Gains from Sales and Divestitures rose 109.34% to $346184.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $346184.0 through Mar 2023, up 109.34% year-over-year, with the annual reading at $218280.0 for FY2022, 5.62% down from the prior year.
  • Gains from Sales and Divestitures for Q1 2023 was $346184.0 at Biolife Solutions, up from $218280.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $448056.0 in Q3 2022, with the low at $53026.0 in Q1 2020.
  • Average Gains from Sales and Divestitures over 5 years is $183621.6, with a median of $163314.5 recorded in 2020.
  • The sharpest move saw Gains from Sales and Divestitures tumbled 34.19% in 2020, then skyrocketed 336.14% in 2021.
  • Over 5 years, Gains from Sales and Divestitures stood at $125818.0 in 2019, then crashed by 34.19% to $82805.0 in 2020, then surged by 179.29% to $231268.0 in 2021, then dropped by 5.62% to $218280.0 in 2022, then skyrocketed by 58.6% to $346184.0 in 2023.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $346184.0, $218280.0, and $448056.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.